Interaction Color Code
Clinical Bottom Line
Do not coadminister: Potential for reduced levels of BIC and TAF
Drug 1
Drug 2
Clinical Effects
Potential decrease in antiretroviral efficacy
Management
Use alternative agents
Import ID
80
